Clinical and electrocardiographic factors associated with adverse cardiovascular events in bupropion exposures

References

• Gummin DD, Mowry JB, Beuhler MC, et al. 2021 annual report of the national poison data system© (NPDS) from America’s poison centers: 39th annual report. Clin Toxicol. 2022;60(12):1381–1643. doi: 10.1080/15563650.2022.2132768.
   PubMed Web of Science ®Google Scholar
• Al-Abri SA, Orengo JP, Hayashi S, et al. Delayed bupropion cardiotoxicity associated with elevated serum concentrations of bupropion but not hydroxybupropion. Clin Toxicol. 2013;51(10):1230–1234. doi: 10.3109/15563650.2013.849349.
   PubMed Web of Science ®Google Scholar
• Biswas AK, Zabrocki LA, Mayes KL, et al. Cardiotoxicity associated with intentional ziprasidone and bupropion overdose. J Toxicol Clin Toxicol. 2003;41(2):101–104. doi: 10.1081/clt-120019121.
   PubMed Web of Science ®Google Scholar
• Franco V. Wide complex tachycardia after bupropion overdose. Am J Emerg Med. 2015;33(10):1540.e3–1540.e5. doi: 10.1016/j.ajem.2015.07.063.
   PubMed Web of Science ®Google Scholar
• Curry SC, Kashani JS, LoVecchio F, et al. Intraventricular conduction delay after bupropion overdose. J Emerg Med. 2005;29(3):299–305. doi: 10.1016/j.jemermed.2005.01.027.
   PubMed Web of Science ®Google Scholar
• Starr P, Klein-Schwartz W, Spiller H, et al. Incidence and onset of delayed seizures after overdoses of extended-release bupropion. Am J Emerg Med. 2009;27(8):911–915. doi: 10.1016/j.ajem.2008.07.004.
   PubMed Web of Science ®Google Scholar
• Morazin F, Lumbroso A, Harry P, et al. Cardiogenic shock and status epilepticus after massive bupropion overdose. Clin Toxicol. 2007;45(7):794–797. doi: 10.1080/15563650701665076.
   Web of Science ®Google Scholar
• Heise CW, Skolnik AB, Raschke RA, et al. Two cases of refractory cardiogenic shock secondary to bupropion successfully treated with veno-arterial extracorporeal membrane oxygenation. J Med Toxicol. 2016;12(3):301–304. doi: 10.1007/s13181-016-0539-7.
   PubMed Web of Science ®Google Scholar
• Overberg A, Morton S, Wagner E, et al. Toxicity of bupropion overdose compared with selective serotonin reuptake inhibitors. Pediatrics. 2019;144(2):e20183295. doi: 10.1542/peds.2018-3295.
   PubMed Web of Science ®Google Scholar
• Manini AF, Nelson LS, Skolnick AH, et al. Electrocardiographic predictors of adverse cardiovascular events in suspected poisoning. J Med Toxicol. 2010;6(2):106–115. doi: 10.1007/s13181-010-0074-x.
   PubMedGoogle Scholar
• Manini AF, Nelson LS, Stimmel B, et al. Incidence of adverse cardiovascular events in adults following drug overdose. Acad Emerg Med. 2012;19(7):843–849. doi: 10.1111/j.1553-2712.2012.01397.x.
   PubMed Web of Science ®Google Scholar
• Manini AF, Hoffman RS, Stimmel B, et al. Clinical risk factors for in-hospital adverse cardiovascular events after acute drug overdose. Acad Emerg Med. 2015;22(5):499–507. doi: 10.1111/acem.12658.
   PubMed Web of Science ®Google Scholar
• Wolkin AF, Martin CA, Law RK, et al. Using poison center data for national public health surveillance for chemical and poison exposure and associated illness. Ann Emerg Med. 2012;59(1):56–61. doi: 10.1016/j.annemergmed.2011.08.004.
   PubMed Web of Science ®Google Scholar
• Carpenter JE, Chang AS, Bronstein AC, et al. Identifying incidents of public health significance using the national poison data system, 2013–2018. Am J Public Health. 2020;110(10):1528–1531. doi: 10.2105/AJPH.2020.305842.
   PubMed Web of Science ®Google Scholar
• Stewart E, Grewal K, Hudson H, et al. Clinical characteristics and outcomes associated with bupropion overdose: a Canadian perspective. Clin Toxicol. 2020;58(8):837–842. doi: 10.1080/15563650.2019.1699658.
   PubMed Web of Science ®Google Scholar
• Shrier M, Díaz JE, Tsarouhas N. Cardiotoxicity associated with bupropion overdose. Ann Emerg Med. 2000;35(1):100. doi: 10.1016/s0196-0644(00)70119-3.
   PubMed Web of Science ®Google Scholar
• Caillier B, Pilote S, Castonguay A, et al. QRS widening and QT prolongation under bupropion: a unique cardiac electrophysiological profile. Fundam Clin Pharmacol. 2012;26(5):599–608. doi: 10.1111/j.1472-8206.2011.00953.x.
   PubMed Web of Science ®Google Scholar
• Offerman S, Gosen J, Thomas SH, et al. Bupropion associated seizures following acute overdose: who develops late seizures. Clin Toxicol. 2020;58(12):1306–1312. doi: 10.1080/15563650.2020.1742919.
   PubMed Web of Science ®Google Scholar
• Ghuran A, Nolan J. The cardiac complications of recreational drug use. West J Med. 2000;173(6):412–415. doi: 10.1136/ewjm.173.6.412.
   PubMedGoogle Scholar
• Robertson SD, Matthies HJ, Galli A. A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters. Mol Neurobiol. 2009;39(2):73–80. doi: 10.1007/s12035-009-8053-4.
   PubMed Web of Science ®Google Scholar
• Kolecki PF, Curry SC. Poisoning by sodium channel blocking agents. Crit Care Clin. 1997;13(4):829–848. doi: 10.1016/s0749-0704(05)70371-7.
   PubMed Web of Science ®Google Scholar
• Sathe AR, Thiemann A, Toulouie S, et al. A 19-year-old woman with a history of depression and fatal cardiorespiratory failure following an overdose of prescribed bupropion. Am J Case Rep. 2021;22:e931783-1–e931783-5. doi: 10.12659/AJCR.931783.
   Web of Science ®Google Scholar
• Shenoi AN, Gertz SJ, Mikkilineni S, et al. Refractory hypotension from massive bupropion overdose successfully treated with extracorporeal membrane oxygenation. Pediatr Emerg Care. 2011;27(1):43–45. doi: 10.1097/PEC.0b013e3182045f76.
   PubMed Web of Science ®Google Scholar
• Givens ML, Gabrysch J. Cardiotoxicity associated with accidental bupropion ingestion in a child. Pediatr Emerg Care. 2007;23(4):234–237. doi: 10.1097/PEC.0b013e31803f5a83.
   PubMed Web of Science ®Google Scholar
• Rianprakaisang TN, Prather CT, Lin AL, et al. Factors associated with seizure development after bupropion overdose: a review of the toxicology investigators consortium. Clin Toxicol. 2021;59:1234–1238.
   PubMed Web of Science ®Google Scholar
• Burnham MP, Sharpe PM, Garner C, et al. Investigation of connexin 43 uncoupling and prolongation of the cardiac QRS complex in preclinical and marketed drugs. Br J Pharmacol. 2014;171(21):4808–4819. doi: 10.1111/bph.12554.
   PubMed Web of Science ®Google Scholar
• Boehnert MT, Lovejoy FH. Value of the QRS duration versus the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants. N Engl J Med. 1985;313(8):474–479. doi: 10.1056/NEJM198508223130804.
   PubMed Web of Science ®Google Scholar
• Sharma ND, Rosman HS, Padhi ID, et al. Torsades de pointes associated with intravenous haloperidol in critically ill patients. Am J Cardiol. 1998;81(2):238–240. doi: 10.1016/s0002-9149(97)00888-6.
   PubMed Web of Science ®Google Scholar
• Roden DM. Predicting drug-induced QT prolongation and torsades de pointes. J Physiol. 2016;594(9):2459–2468. doi: 10.1113/JP270526.
   PubMed Web of Science ®Google Scholar
• Tisdale JE, Chung MK, Campbell KB, et al. Drug-Induced arrhythmias: a scientific statement from the American heart association. Circulation. 2020;142(15):e214–e233. doi: 10.1161/CIR.0000000000000905.
   PubMed Web of Science ®Google Scholar
• Isbister GK, Balit CR. Bupropion overdose: QTc prolongation and its clinical significance. Ann Pharmacother. 2003;37(7–8):999–1002. doi: 10.1345/aph.1C481.
   PubMed Web of Science ®Google Scholar
• Zeltser D, Justo D, Halkin A, et al. Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors. Medicine. 2003;82(4):282–290. doi: 10.1097/01.md.0000085057.63483.9b.
   PubMed Web of Science ®Google Scholar
• Mangona E, Sandonato E, Brothers TN, et al. Drug-induced QTc prolongation: what we know and where we are going. Curr Drug Saf. 2022;17(2):100–113. doi: 10.2174/1574886316666210922153059.
   PubMed Web of Science ®Google Scholar
• Liebelt EL, Francis PD, Woolf AD. ECG lead aVR versus QRS interval in predicting seizures and arrhythmias in acute tricyclic antidepressant toxicity. Ann Emerg Med. 1995;26(2):195–201. doi: 10.1016/s0196-0644(95)70151-6.
   PubMed Web of Science ®Google Scholar
• Foulke GE, Albertson TE. QRS interval in tricyclic antidepressant overdosage: inaccuracy as a toxicity indicator in emergency settings. Ann Emerg Med. 1987;16(2):160–163. doi: 10.1016/s0196-0644(87)80006-9.
   PubMed Web of Science ®Google Scholar
• Manini AF, Nair AP, Vedanthan R, et al. Validation of the prognostic utility of the electrocardiogram for acute drug overdose. J Am Heart Assoc. 2017;6(2):e004320.
   PubMed Web of Science ®Google Scholar
• Seger D, Hantsch C, Zavoral T, et al. Variability of recommendations for serum alkalinization in tricyclic antidepressant overdose: a survey of U.S. poison center medical directors. J Toxicol Clin Toxicol. 2003;41(4):331–338. doi: 10.1081/clt-120021999.
   PubMed Web of Science ®Google Scholar
• Bruccoleri RE, Burns MM. A literature review of the use of sodium bicarbonate for the treatment of QRS widening. J Med Toxicol. 2016;12(1):121–129. doi: 10.1007/s13181-015-0483-y.
   PubMedGoogle Scholar
• Hoffman JR, Votey SR, Bayer M, et al. Effect of hypertonic sodium bicarbonate in the treatment of moderate-to-severe cyclic antidepressant overdose. Am J Emerg Med. 1993;11(4):336–341. doi: 10.1016/0735-6757(93)90163-6.
   PubMed Web of Science ®Google Scholar
• Wills BK, Zell-Kanter M, Aks SE. Bupropion-associated QRS prolongation unresponsive to sodium bicarbonate therapy. Am J Ther. 2009;16(2):193–196. doi: 10.1097/MJT.0b013e3180a5bd83.
   PubMed Web of Science ®Google Scholar
• Shastry S, Ellis J, Loo G, et al. Antidotal sodium bicarbonate therapy: delayed QTc prolongation and cardiovascular events. J Med Toxicol. 2021;17(1):27–36. doi: 10.1007/s13181-020-00799-z.
   PubMed Web of Science ®Google Scholar
• Chhabra N, DesLauriers C, Wahl M, et al. Management of severe bupropion poisoning with intravenous lipid emulsion. Clin Toxicol. 2018;56(1):51–54. doi: 10.1080/15563650.2017.1337909.
   PubMed Web of Science ®Google Scholar
• Gosselin S, Hoegberg LCG, Hoffman Robert S, et al. Evidence-based recommendations on the use of intravenous lipid emulsion therapy in poisoning. Clin Toxicol. 2016;54(10):899–923. doi: 10.1080/15563650.2016.1214275.
   PubMed Web of Science ®Google Scholar